Skip to content
2000
Volume 24, Issue 7
  • ISSN: 1871-5265
  • E-ISSN: 2212-3989

Abstract

Zika virus (ZIKV) is among the relatively new infectious disease threats that include SARS-CoV-2, coronavirus, monkeypox (Mpox) virus, . ZIKV has been reported to cause severe health risks to the fetus. To date, satisfactory treatment is still not available for the treatment of ZIKV infection. This review examines the last five years of work using natural biomolecules (BMs) to counteract the ZIKV through virtual screening and investigations. Virtual screening has identified doramectin, pinocembrin, hesperidins, epigallocatechin gallate, pedalitin, and quercetin as potentially active versus ZIKV infection. , testing has shown that nordihydroguaiaretic acid, mefloquine, isoquercitrin, glycyrrhetinic acid, patentiflorin-A, rottlerin, and harringtonine can reduce ZIKV infections in cell lines. However, , testing is limited, fortunately, emetine, rottlerin, patentiflorin-A, and lycorine have shown anti- ZIKV potential. This review focuses on natural biomolecules that show a particularly high selective index (>10). There is limited and clinical trial data for natural BMs, which needs to be an active area of investigation. This review aims to compile the known reference data and discuss the barriers associated with discovering and using natural BM agents to control ZIKV infection.

Loading

Article metrics loading...

/content/journals/iddt/10.2174/0118715265272414231226092146
2024-11-01
2024-11-06
Loading full text...

Full text loading...

/content/journals/iddt/10.2174/0118715265272414231226092146
Loading
  • Article Type: Review Article
Keyword(s): Biomolecules; IC50; in-vitro; Virtual; virtual screening; ZIKV
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test